Theral TimpsonUnclaimed
Host of Mendelspod Podcast.
1 Feed-stated
Counts Verified and Feed-stated credits: what a show's own feed states, or a confirmation backs. See the record
- Host
Claim this profile Add a creditIs this you? Claiming needs a free account. You sign in or join, then come straight back here.
This profile is unclaimed. PodSubs built it from public show feeds and credits. The person it is about has not reviewed it yet.
About
Theral hosts Mendelspod Podcast.
Written by PodSubs from Theral's credits.
PodCred record
PodCred is the verified record of where Theral has worked and appeared. These credits come from the shows' own feeds and wait for people who were there to confirm them.
Worked with Theral on a show? This is where you give them credit.
Shows they work on now
1 show
Is an appearance missing?
People get invited back because someone remembered they were great. If you heard this person on a show and it is not listed here, add it. Your memory might be the reason they get their next invitation.
No account needed. Anyone can give a credit.
Experience, education, skills, and recommendations start empty. They fill in when Theral claims this profile.
Recommendations
No recommendations for Theral yet.
Recommendations open once Theral claims the profile.
Activity
0 followers
No posts yet. Posts Theral shares on PodSubs, and what Theral publishes on Substack, YouTube and elsewhere, will show here.
Recent episodes
From the shows they work on now
When to Begin Developing the Companion Diagnostic? With Gulzar Sandhu, Agilent Technologies
When should a pharma company begin developing the diagnostic that will identify which patients benefit from a new drug? Early enough to avoid costly delays, but not so early that the company limits the possibilities for...
The $60 Genome, Virtual Cell Modeling and the Future of Biology, with Gilad Almogy, Ultima Genomics
This is a free preview of a paid episode. To hear more, visit www.mendelspod.com Can we scale our way to a better understanding of biology? When we first had the CEO and founder of Ultima Genomics on the show, the...
Precision Oncology 2.0: From Tumor Profiling to Continuous Monitoring with Jerry Radich, Fred Hutch
Precision oncology is entering a new phase. Rather than simply profiling a tumor and matching it to a drug, physicians are increasingly able to follow a patient’s cancer over time, measuring treatment response,...
The UK’s Next Big Bet on Precision Medicine: Our Future Health with CEO Raghib Ali
In the US, we have the All of Us Research Program. In the UK, they have Our Future Health, an ambitious new population health research program that aims to make healthcare more preventive than reactive. Launched just...
From the Archives: The Dark Genome Is Coming Into Focus with Sudhakaran Prabakaran
In recent months on Mendelspod, we’ve explored how new sequencing and proteomics technologies are revealing biology in regions of the genome (and proteome) that have long escaped our attention. From repeat expansion...
Repeat Expansions and the Promise of Long Reads with Alex Lindell and Simon Sadedin
Repeat expansions are places where the genome has remained stubbornly dark. Long-read sequencing is beginning to illuminate them, and now that new visibility is moving into clinical testing. Today we’re joined by Simon...
How Roswell Park Is Rethinking Molecular Testing for Blood Cancers with Sean Glenn
Sometimes the best evidence that a new medical technology is working is simply that doctors start depending on it. For years, the promise of molecular medicine has been that better genomic information would lead to...
Building a Single Cell Atlas of the Poplar Tree with Robin Buell and Anita Giabardo
Plant biology too is benefiting from single cell resolution. Unlike animals, plants cannot move away from environmental stress. They have evolved tremendous biological complexity to stay rooted in one place. Their...
Three Illumina 5-Base Grant Contest Winners Share Cancer Research Insights from Combining Epigenetics and Genetics
What new insights can we learn about cancer when researchers are able to look at the genome and the methylome together? Recently, Illumina launched its 5-base for Cancer Research Grant Contest to explore that question....
Ten Years Ago Mike Joyner Was Skeptical of Precision Medicine. What Does He Say Today?
This is a free preview of a paid episode. To hear more, visit www.mendelspod.com A recent New York Times article highlighted a remarkable study showing that exercise can help keep colon cancer in remission. After eight...
